Topline data on the chemotherapy experienced cohort of the Phase II PSMA ADC trial will be presented at the American Society of Clinical Oncology's 2014 Genitourinary Cancers Symposium Meeting in San Francisco in January 2014. January 30th to be exact http://ir.progenics.com/releasedetail.cfm?ReleaseID=812337